Graduate School of Medicine Department of Clinical Medical Science 

Lecturer  2025.04 - Now

School of Medicine Department of Medical Science 

Lecturer  2025.04 - Now

博士（医学） （ Osaka City University ）

Prognostic Impact of Residual T and N Status After Neoadjuvant Therapy in Breast Cancer.

Fujioka S, Kashiwagi S, Kikukawa Y, Watanabe C, Takada K, Tauchi Y, Ogisawa K, Shibutani M, Kinoshita H, Morisaki T, Yoshimura K

Anticancer research   46 ( 2 )   939 - 947   2026.02（ ISSN:0250-7005 ）

Clinicopathological Significance of HER2 Expression Redefined by the HER2-low Concept in Ductal Carcinoma In Situ

Takada K.

Anticancer Research   46 ( 2 )   901 - 909   2026.02（ ISSN:02507005 ）

Efficacy and Safety of Subcutaneous Pertuzumab-Trastuzumab (Phesgo) in Neoadjuvant Treatment of HER2-positive Breast Cancer: Real-world Data from Japan

KINOSHITA H.

Anticancer Research   46 ( 1 )   293 - 300   2026.01（ ISSN:02507005 ）

Assessment of the Role of Neutrophil-Lymphocyte Ratio as a Prognostic Biomarker in Breast Cancer Patients: A Cross-sectional Study

Takada K.

Cancer Diagnosis and Prognosis   6 ( 1 )   70 - 81   2026.01

Clinical–Genomic Risk Discordance in Early HR+/HER2–Breast Cancer: A Real-World Cohort from Japan Demonstrates Treatment Impact of Oncotype DX

Henmi S.

Anticancer Research   46 ( 1 )   439 - 446   2026.01（ ISSN:02507005 ）

第１３回ＦＤ講習会  2025